1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Analysis

Summary
Canadean's "Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, mergers and acquisitions, recent developments, key employees as well as company locations and subsidiaries.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about "Grupo Ferrer Internacional, S.A."

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
Grupo Ferrer Internacional, S.A. (Ferrer) is a pharmaceutical company based in Spain. The company manufactures and markets pharmaceutical products for various therapeutic areas such as cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, musculoskeletal system, pain management, pediatrics and the respiratory system. It also offers diagnostics services through its subsidiary Ferrer inCode. Apart from these, Ferrer offers vaccine solutions for allergies, generic drugs and consumer healthcare products such as dermocosmetics, sunscreens, food supplements, infant nutrition products, over-the counter medicines, insect repellants and antilice products. The company also offers fine chemicals, and food and feed ingredients. It operates production facilities across Germany, Mexico and Spain. The company also operates a logistics center in Spain. Ferrer is headquartered in Barcelona, Spain.

- This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

- The SWOT analysis identifies the company's strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

- The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Reasons To Buy
- Quickly enhance your understanding of "Grupo Ferrer Internacional, S.A."

- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

- Increase business/sales activities by understanding your competitors' businesses better.

- Recognize potential partnerships and suppliers.

Key Highlights
Grupo Ferrer Internacional, S.A. (Ferrer) is a pharmaceutical company based in Spain. The company manufactures and markets pharmaceutical products for various therapeutic areas such as cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, musculoskeletal system, pain management, pediatrics and the respiratory system. It also offers diagnostics services through its subsidiary Ferrer inCode. Apart from these, Ferrer offers vaccine solutions for allergies, generic drugs and consumer healthcare products such as dermocosmetics, sunscreens, food supplements, infant nutrition products, over-the counter medicines, insect repellants and antilice products. The company also offers fine chemicals, and food and feed ingredients. It operates production facilities across Germany, Mexico and Spain. The company also operates a logistics center in Spain. Ferrer is headquartered in Barcelona, Spain.

Table Of Contents

Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Analysis
Table of Contents
1 Grupo Ferrer Internacional, S.A.
2 Grupo Ferrer Internacional, S.A. - Key Employees
3 Grupo Ferrer Internacional, S.A. - Major Products and Services
4 Grupo Ferrer Internacional, S.A. - History
5 Grupo Ferrer Internacional, S.A. - Locations and Subsidiaries
5.1 Grupo Ferrer Internacional, S.A. - Head Office
5.2 Grupo Ferrer Internacional, S.A. - Other Locations and Subsidiaries
6 Grupo Ferrer Internacional, S.A. - Business Analysis
6.1 Grupo Ferrer Internacional, S.A. - Company Overview
6.2 Grupo Ferrer Internacional, S.A. - Business Description
7 Grupo Ferrer Internacional, S.A. - SWOT Analysis
7.1 Grupo Ferrer Internacional, S.A. - SWOT Analysis - Overview
7.2 Grupo Ferrer Internacional, S.A. - Strengths
7.2.1 Strength - Focus on Quality and Product Safety
7.2.2 Strength - Diverse Presence across Healthcare Sector
7.2.3 Strength - Focus on Research and Development and Innovation
7.3 Grupo Ferrer Internacional, S.A. - Weaknesses
7.3.1 Weaknesses - Geographic Concentration of Revenues
7.4 Grupo Ferrer Internacional, S.A. - Opportunities
7.4.1 Opportunities - Positive Outlook for the Global Pharmaceutical Industry
7.4.2 Opportunities - Increasing Demand for Omega-3 Fatty Acids
7.4.3 Opportunities - Growth Initiatives
7.5 Grupo Ferrer Internacional, S.A. - Threats
7.5.1 Threats - Expansion by Competitors
7.5.2 Threats - Stringent Regulations in Europe
7.5.3 Threats - Shortage of Skilled Labor in Europe
8 Grupo Ferrer Internacional, S.A. - Mergers and Acquisitions and Partnerships
8.1 Grupo Ferrer Internacional, S.A. - MandA and Partnerships Strategy
9 Grupo Ferrer Internacional, S.A. - Recent Developments
10 Appendix
10.1 Methodology
10.2 Disclaimer

List of Tables
Table 1: Grupo Ferrer Internacional, S.A. - Key Employees
Table 2: Grupo Ferrer Internacional, S.A. - Major Products and Services
Table 3: Grupo Ferrer Internacional, S.A. - History
Table 4: Grupo Ferrer Internacional, S.A. - Subsidiaries
Table 5: Grupo Ferrer Internacional, S.A. - Locations

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.